BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21888995)

  • 1. Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: a very mild phenotype.
    Jonard L; Couloigner V; Pierrot S; Louha M; Gherbi S; Denoyelle F; Marlin S
    Eur J Med Genet; 2012 Jan; 55(1):56-8. PubMed ID: 21888995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
    Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
    Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.
    Melki I; Lambot K; Jonard L; Couloigner V; Quartier P; Neven B; Bader-Meunier B
    Pediatrics; 2013 Apr; 131(4):e1308-13. PubMed ID: 23530176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease.
    Colmenero I; Molho-Pessach V; Torrelo A; Zlotogorski A; Requena L
    Am J Dermatopathol; 2012 May; 34(3):315-20. PubMed ID: 22356918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset sensorineural hearing loss is a prominent feature of H syndrome.
    Ramot Y; Sayama K; Sheffer R; Doviner V; Hiller N; Kaufmann-Yehezkely M; Zlotogorski A
    Int J Pediatr Otorhinolaryngol; 2010 Jul; 74(7):825-7. PubMed ID: 20399510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.
    Elbarbary NS; Tjora E; Molnes J; Lie BA; Habib MA; Salem MA; Njølstad PR
    Pediatr Diabetes; 2013 Sep; 14(6):466-72. PubMed ID: 22989030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H syndrome: the first 79 patients.
    Molho-Pessach V; Ramot Y; Camille F; Doviner V; Babay S; Luis SJ; Broshtilova V; Zlotogorski A
    J Am Acad Dermatol; 2014 Jan; 70(1):80-8. PubMed ID: 24172204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
    Avitan-Hersh E; Mandel H; Indelman M; Bar-Joseph G; Zlotogorski A; Bergman R
    Am J Dermatopathol; 2011 Feb; 33(1):47-51. PubMed ID: 21178579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.
    de Jesus J; Imane Z; Senée V; Romero S; Guillausseau PJ; Balafrej A; Julier C
    Diabetes Metab; 2013 May; 39(3):281-5. PubMed ID: 23623699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
    Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
    PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
    Farooq M; Moustafa RM; Fujimoto A; Fujikawa H; Abbas O; Kibbi AG; Kurban M; Shimomura Y
    Dermatology; 2012; 224(3):277-84. PubMed ID: 22653152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome.
    Al-Haggar M; Salem N; Wahba Y; Ahmad N; Jonard L; Abdel-Hady D; El-Hawary A; El-Sharkawy A; Eid AR; El-Hawary A
    Pediatr Diabetes; 2015 Jun; 16(4):305-16. PubMed ID: 24894595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the clinical spectrum of SLC29A3 gene defects.
    Spiegel R; Cliffe ST; Buckley MF; Crow YJ; Urquhart J; Horovitz Y; Tenenbaum-Rakover Y; Newman WG; Donnai D; Shalev SA
    Eur J Med Genet; 2010; 53(5):309-13. PubMed ID: 20619369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H syndrome: novel and recurrent mutations in SLC29A3.
    Priya TP; Philip N; Molho-Pessach V; Busa T; Dalal A; Zlotogorski A
    Br J Dermatol; 2010 May; 162(5):1132-4. PubMed ID: 20199539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H syndrome with a novel homozygous SLC29A3 mutation in two sisters.
    Demir D; Aktaş Karabay E; Sözeri B; Gürsoy F; Akgün Doğan Ö; Topaktaş E; Zindancı İ
    Pediatr Dermatol; 2020 Nov; 37(6):1135-1138. PubMed ID: 32776596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel homozygous frame-shift mutation in the SLC29A3 gene: a new case report and review of literature.
    Noavar S; Behroozi S; Tatarcheh T; Parvini F; Foroutan M; Fahimi H
    BMC Med Genet; 2019 Aug; 20(1):147. PubMed ID: 31464584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound heterozygous SLC29A3 mutation causes H syndrome in a Moroccan patient: A case report.
    Bakhchane A; Kindil Z; Charoute H; Benchikhi K; Khadir K; Nadifi S; Baline K; Roky R; Barakat A
    Curr Res Transl Med; 2016; 64(2):65-8. PubMed ID: 27316388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygosity for a novel large deletion in SLC29A3 in a patient with H syndrome.
    Shankar SG; Rangarajan S; Priyadarshini A; Swaminathan A; Sundaram M
    Pediatr Dermatol; 2020 Mar; 37(2):333-336. PubMed ID: 31867772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H syndrome: Clinical, histological and genetic investigation in Tunisian patients.
    Jaouadi H; Zaouak A; Sellami K; Messaoud O; Chargui M; Hammami H; Jones M; Jouini R; Chadli Debbiche A; Chraiet K; Fenniche S; Mrad R; Mokni M; Turki H; Benkhalifa R; Abdelhak S
    J Dermatol; 2018 Aug; 45(8):978-985. PubMed ID: 29808591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized pure cutaneous Rosai-Dorfman disease: a link between inflammation and cancer not associated with mitochondrial DNA and SLC29A3 gene mutation?
    Zheng M; Bi R; Li W; Landeck L; Chen JQ; Lao LM; Cai SQ; Yao YG; Man XY
    Discov Med; 2013 Nov; 16(89):193-200. PubMed ID: 24229736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.